Professor Ahmed Ahmed
Contact information
Jingyi Sang
jingyi.sang@wrh.ox.ac.uk
Collaborators
-
Mara Artibani
Postdoctoral Research Assistant in Cancer Stem Cells
-
Lena Rai
Postdoctoral Research Assistant in Ovarian Cancer
-
May Sallam
Postdoctoral Research Assistant in Stem Cell Biology
-
Luyao Wang
Postdoctoral Research Assistant in Translational Cancer Immunology
-
Nancy Zaarour
Research Fellow
-
Aneesh Aggarwal
MSc by Research Student
-
Jingyi Sang
PA to Prof Ahmed Ahmed
Ahmed Ahmed
MBBCH, MSc, MD, MRCOG, PhD
Professor of Gynaecological Oncology
- Consultant Gynaecological Oncology Surgeon
- Director of the Ovarian Cancer Cell Laboratory at the Weatherall Institute of Molecular Medicine
Research groups
Latest Paper
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells Click here to read

Click here to watch video: "Scientists closer to finding the cell of origin for ovarian cancer"
BIOGRAPHY
I am a Professor of Gynaecological Oncology at the Nuffield Department of Women's & Reproductive Health at the University of Oxford and a Consultant Gynaecological Oncology Surgeon at the Oxford Cancer and Haematology Centre and is a Fellow of St Hugh’s College. I lead laboratory-based translational research in Gynaecological Oncology. My main research interest is in the surgical, medical and fundamental research into ovarian cancer. I graduated from Ain Shams University in Cairo, Egypt and completed my PhD and Gynaecological Oncology Surgical training at the University of Cambridge. I received my postdoctoral research training at the University of Cambridge and at the University of Texas, M.D. Anderson Cancer Centre in the USA. I was appointed as a Clinical Reader in Oxford in 2010 and became a Medical Research Council Senior Clinical Research Fellow at the Weatherall Institute of Molecular Medicine and Professor of Gynaecological Oncology in 2012.
Colleges
Key publications
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.
Conference paper
Prota G. et al, (2020), Cancer Immunol Res, 8, 685 - 697
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes.
Journal article
KaramiNejadRanjbar M. et al, (2020), Elife, 9
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
Journal article
Hu Z. et al, (2020), Cancer Cell, 37, 226 - 242.e7
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
Journal article
Bast RC. et al, (2019), Cancer, 125, 1963 - 1972
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Journal article
Zheng Y. et al, (2018), Nat Commun, 9
A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay.
Journal article
Hu Z. et al, (2017), Nat Commun, 8
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche.
Journal article
Miranda F. et al, (2016), Cancer Cell, 30, 273 - 289
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.
Journal article
Hellner K. et al, (2016), EBioMedicine, 10, 137 - 149
SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.
Journal article
Ahmed AA. et al, (2010), Cancer Cell, 18, 109 - 121
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Journal article
Ahmed AA. et al, (2010), J Pathol, 221, 49 - 56
Recent publications
Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention.
Journal article
Wang L. et al, (2026), Nat Commun
Whole genome sequencing of endometrial cancer identifies novel subgroups, drivers, and actionable alterations
Preprint
Meyer S. et al, (2026)
Rethinking ovarian cancer III: the past decade and future directions.
Journal article
Balkwill FR. et al, (2026), Nat Rev Cancer